CurifyLabs enables pharmacies to deliver personalized, safe, and efficient treatments by transforming manual compounding into an automated, scalable process.

Company Background
CurifyLabs is a health tech company revolutionizing personalized medicine in pharmacies and hospitals, by providing technology that automates compounding — transforming a traditionally manual, time-intensive process into a streamlined, accurate system. CurifyLabs Compounding System Solution (CSS) is an automated pharmaceutical platform for compounding non-sterile dosage forms, including tablets, troches, films, liquids, suppositories, ovules, ointments, and capsules. Already in use across Europe and the USA, CurifyLabs CSS enables better patient treatments and greater pharmacy efficiency.

Developed with pharmacists and backed by over a decade of academic research, CSS is inspired by 3D printing to address workforce shortages and cost pressures while aligning with FDA 503A/503B standards. By embracing trends such as pharmacogenomics and at-home diagnostics, CurifyLabs helps healthcare systems deliver personalized therapies safely, efficiently, and at scale.

Product Overview
The CurifyLabs CSS is a complete toolkit designed to transform nonsterile compounding, improving patient outcomes while ensuring safer, more efficient pharmacy operations. At its core, the system combines three elements: a digital platform with validated, standardized formularies and quality documentation; GMP manufactured, IP-protected excipient bases engineered for compatibility; and robotics inspired by 3D printing that automate the entire workflow from prescription to finished dosage form.

This integrated approach gives pharmacies unique capabilities. Formulations can be tailored by adjusting dose, shape, taste, and release profile across all major therapeutic areas. The platform also supports combination therapies, or polypills, and produces multiple dosage forms, including gel tablets, troches, chewables, liquids, and films. A comprehensive library containing stability data, dissolution profiles, and other quality assurance metrics underpins every step of the process.

The benefits are substantial. CSS enables compounding up to four times faster than manual methods, while built-in quality control safeguards reduce regulatory burden and minimize human error. Standardized, validated processes extend shelf-life and lower contamination risks, while automation protects staff from repetitive strain and hazardous exposure. Validated by 30+ pharmacists and adopted by leading hospitals in 14+ markets, CSS is designed by pharmacists for pharmacists and is fully compliant with current U.S. compounding regulations.

At the foundation of CSS are the company’s CuraBlend® excipient bases, developed to bring consistency, safety, and efficiency to modern compounding. Produced under GMP-certified conditions, they are lactose-free and designed with low water activity (<0.6) to support USP-compliant beyond-use dating. All are optimized for automated dispensing, covering therapeutic needs from newborns to the elderly.

• CuraBlend® Water Free Tablet Excipient Base provides a stable, heat-resistant option for immediate-release tablets and troches, with high API loading and smooth taste for better compliance, even in hot climates.
• CuraBlend® Anhydrous Troche Excipient Base offers a soft, melt-inthe- mouth texture with excellent taste masking and immediate release.
• CuraBlend® Suppository Excipient Base ensures wide API compatibility and predictable melting at body temperature for safe and consistent release.
• CuraBlend® Gel Tablet Excipient Base supports innovative gel tablets and gummies, especially for patients with swallowing difficulties, combining suspendability with a smooth, taste-masked texture.

Part of the Compounding System Solution, CurifyLabs Create is an intuitive software tool that lets pharmacists design and adapt formulations directly from pure APIs or crushed tablets. This gives pharmacies the flexibility to prepare therapies on demand, even when APIs are required on short notice. The platform expands access to a wide range of dosage forms, including those requiring specialized handling, while its intuitive workflow simplifies the process without compromising safety or precision.

By combining ease of use with professional autonomy, CurifyLabs Create empowers pharmacists to move beyond standard formularies and craft treatments tailored to patient needs. It bridges advanced compounding technology and the clinical creativity required for modern, personalized medicine.

Trade Shows/Meetings Attended
CurifyLabs has a strong presence at leading industry events across the United States and Europe, including the American Society of Health- System Pharmacists (ASHP), the European Association of Hospital Pharmacists (EAHP), and the Alliance for Pharmacy Compounding (APC). For details on upcoming appearances at international fairs and conferences, visit the events page on CurifyLabs website.